To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.

SIGNUP

Already Have an Account?

Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Ace Report Cover

Ifosfamide-based chemotherapy yields high survival rate for treatment of osteosarcoma

Download
Share
Reprints
Cite This
About
+ Favorites
Share
Reprints
Cite This
About
+ Favorites
Ace Report Cover
August 2020

Ifosfamide-based chemotherapy yields high survival rate for treatment of osteosarcoma

Vol: 9| Issue: 8| Number:12| ISSN#: 2564-2537
Study Type:Meta analysis
OE Level Evidence:1
Journal Level of Evidence:N/A

Efficacy and safety of ifosfamide-based chemotherapy for osteosarcoma: a meta-analysis

Drug Des Devel Ther. 2015 Nov 4;9:5925-32

Contributing Authors:
XL Fan GP Cai LL Zhu GM Ding

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

Synopsis

Seven randomized controlled trials with 2,529 patients with histologically confirmed osteosarcoma were included in this meta-analysis. The purpose of this study was to compare the safety and efficacy of ifosfamide-based chemotherapy to a control group receiving chemotherapy without ifosfamide. The results displayed that ifosfamide-based chemotherapy had significantly higher event-free survival, ov...

CME Image

Did you know that you’re eligible to earn 0.5 CME credits for reading this report!

LEARN MORE

Join the Conversation

Please Login or Join to leave comments.